Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting

Autor: Miyahira, AK, Lang, JM, Den, RB, Garraway, IP, Lotan, TL, Ross, AE, Stoyanova, T, Cho, SY, Simons, JW, Pienta, KJ, Soule, HR

Publikováno v: The Prostate, vol 76, iss 2
Miyahira, AK; Lang, JM; Den, RB; Garraway, IP; Lotan, TL; Ross, AE; et al.(2015). Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting. Prostate. doi: 10.1002/pros.23107. UCLA: Retrieved from: http://www.escholarship.org/uc/item/5m81w7ht

© 2015 Wiley Periodicals, Inc. Background: The 2015 Coffey-Holden Prostate Cancer Academy Meeting, themed: "Multidisciplinary Intervention of Early, Lethal Metastatic Prostate Cancer," was held in La Jolla, California from June 25 to 28, 2015. Metho

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::b74a586904b8c4c72a6fb185305c65d2
https://escholarship.org/uc/item/5m81w7ht

Personalized Medicine: Leave no Patient Behind; Report From the 2024 Coffey-Holden Prostate Cancer Academy Meeting.

Autor: Miyahira AK; Department of Science, Prostate Cancer Foundation, Santa Monica, California, USA., Sharifi M; Department of Medicine and Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin, USA., Chesner LN; Department of Radiation Oncology, University of California, San Francisco, San Francisco, California, USA., El-Kenawi A; Department of Urology, Indiana University School of Medicine, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA., Haas R; Department of Human Genetics, University of California, Los Angeles, Los Angeles, California, USA., Sena LA; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA., Tewari AK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Pienta KJ; The James Buchanan Brady Urological Institute, The Johns Hopkins School of Medicine, Baltimore, Maryland, USA., Soule HR; Department of Science, Prostate Cancer Foundation, Santa Monica, California, USA.

Publikováno v: The Prostate [Prostate] 2024 Nov 27. Date of Electronic Publication: 2024 Nov 27.

Disrupting prostate cancer research: Challenge accepted; report from the 2023 Coffey-Holden Prostate Cancer Academy Meeting.

Autor: Miyahira AK; Science Department, Prostate Cancer Foundation, Santa Monica, California, USA., Kamran SC; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Jamaspishvili T; Department of Pathology and Laboratory Medicine, SUNY Upstate Medical University, Syracuse, New York, USA., Marshall CH; Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Maxwell KN; Department of Medicine-Hematology/Oncology and Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Medicine Service, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania, USA., Parolia A; Department of Pathology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA., Zorko NA; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.; University of Minnesota Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA., Pienta KJ; The James Buchanan Brady Urological Institute, The Johns Hopkins School of Medicine, Baltimore, Maryland, USA., Soule HR; Science Department, Prostate Cancer Foundation, Santa Monica, California, USA.

Publikováno v: The Prostate [Prostate] 2024 Aug; Vol. 84 (11), pp. 993-1015. Date of Electronic Publication: 2024 Apr 29.

Exploring new frontiers in prostate cancer research: Report from the 2022 Coffey-Holden prostate cancer academy meeting.

Autor: Miyahira AK; Prostate Cancer Foundation, Santa Monica, California, USA., Hawley JE; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington, USA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Adelaiye-Ogala R; Department of Medicine, Division of Hematology and Oncology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA.; Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA., Calais J; Department of Molecular and Medical Pharmacology, Ahmanson Translational Imaging Division, University of California, Los Angeles, Los Angeles, California, USA., Nappi L; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, British Columbia, Canada.; Department of Medical Oncology, BC Cancer, British Columbia, Canada., Parikh R; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania, USA., Seibert TM; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California, USA.; Department of Radiology, University of California San Diego, La Jolla, California, USA.; Department of Bioengineering, University of California San Diego, La Jolla, California, USA.; Research Service, VA San Diego Healthcare System, San Diego, California, USA., Wasmuth EV; Department of Biochemistry and Structural Biology, University of Texas Health at San Antonio, San Antonio, Texas, USA., Wei XX; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Pienta KJ; The James Buchanan Brady Urological Institute, The Johns Hopkins School of Medicine, Baltimore, Maryland, USA., Soule HR; Prostate Cancer Foundation, Santa Monica, California, USA.

Publikováno v: The Prostate [Prostate] 2023 Feb; Vol. 83 (3), pp. 207-226. Date of Electronic Publication: 2022 Nov 28.

The History of Prostate-Specific Membrane Antigen as a Theranostic Target in Prostate Cancer: The Cornerstone Role of the Prostate Cancer Foundation.

Autor: Miyahira AK; Science Department, Prostate Cancer Foundation, Santa Monica, California amiyahira@pcf.org., Soule HR; Science Department, Prostate Cancer Foundation, Santa Monica, California.

Publikováno v: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2022 Mar; Vol. 63 (3), pp. 331-338. Date of Electronic Publication: 2021 Oct 21.